PROCEPT BioRobotics Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
PROCEPT BioRobotics Corporation (PRCT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $38.50 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2026-08-05
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $38.50M.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $44.70M.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $61.00M.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $79.80M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2026-06-30 | $38.50M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $44.70M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $61.00M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $79.80M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $154.80M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $162.30M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $239.70M 10-Q · filed 2025-11-05 |
| 2024-09-30 | $271.40M 10-Q · filed 2024-10-28 |
| 2024-06-30 | $203.70M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $168.30M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $144.00M 10-Q · filed 2024-10-28 |
| 2023-09-30 | $106.80M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $112.20M 10-Q · filed 2023-07-28 |
| 2023-03-31 | $84.60M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $126.30M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $94.60M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $64.30M 10-Q · filed 2022-05-06 |
| 2021-09-30 | $98.70M 10-Q · filed 2021-11-05 |
| 2020-12-31 | $6.90M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |